CCL
 
HOME    |    ABOUT JOURNAL    |    EDITORIAL BOARD    |    INTRODUCTION    |    SUBSCRIPTIONS    |    DOWNLOAD    |    CONTACT US
Email Alert
RSS
Chinese Chemical Letters  2021, Vol. 32 Issue (05): 1660-1664    DOI: 10.1016/j.cclet.2020.12.023
Communications Current Issue | Archive | Adv Search |
Repurposing of antitumor drug candidate Quisinostat lead to novel spirocyclic antimalarial agents
Ruoxi Lia, Dazheng Linga, Tongke Tangb,e, Zhenghui Huangb, Manjiong Wanga, Fei Maoa, Jin Zhua, Lubin Jiangb,e, Jian Lia,c,d, Xiaokang Lia
a State Key Laboratory of Bioreactor Engineering, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China;
b Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai 200031, China;
c College of Pharmacy and Chemistry, Dali University, Dali 671000, China;
d Frontiers Science Center for Materiobiology and Dynamic Chemistry, East China University of Science and Technology, Shanghai 200237, China;
e School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China
Links
 
Copyright © 2015 Editorial Office of Chinese Chemical Letters
Address: 1 Xian Nong Tan Street, Xicheng District, Beijing, China
Zip code: 100050 Tel: 86-10-63165638 Email: cclbj@imm.ac.cn